We are live on ! Find out more
FLACU

Frazier Lifesciences Acquisition Corporation Unit

Delisted

FLACU was delisted on the 22nd of November, 2022.

17 hedge funds and large institutions have $32.7M invested in Frazier Lifesciences Acquisition Corporation Unit in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less capital invested

Capital invested by funds: $35.8M → $32.7M (-$3.1M)

19% less funds holding

Funds holding: 2117 (-4)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
17
Holders Change
-4
Holders Change %
-19.05%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
3
Closed
4
Calls
Puts
Net Calls
Net Calls Change

FLACU Hedge Fund Activity: Q2 2022 in Review

17 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Unit (FLACU) for Q2 2022, worth a combined $32.7M — down 8.7% from $35.8M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of FLACU and 0 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Glazer Capital LLC, adding an estimated $261K. The largest seller was Wolverine Asset Management, cutting an estimated $1.55M.

  • 17 institutional investors held Frazier Lifesciences Acquisition Corporation Unit (FLACU) as of Q2 2022, down from 21 in Q1 2022.
  • Funds reported $32.7M of Frazier Lifesciences Acquisition Corporation Unit stock for Q2 2022, down 8.7% quarter-over-quarter.
  • 0 funds opened new Frazier Lifesciences Acquisition Corporation Unit positions in Q2 2022 and 4 closed out, a net change of -4 holders.
  • The largest Frazier Lifesciences Acquisition Corporation Unit buyer in Q2 2022 was Glazer Capital LLC, an estimated $261K added.
  • The largest Frazier Lifesciences Acquisition Corporation Unit seller in Q2 2022 was Wolverine Asset Management, an estimated $1.55M sold.

Based on aggregated 13F filings for Q2 2022.